Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Breast Cancer × Selective Estrogen Receptor Modulators × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Advanced Breast Cancer 1

Interventions

elacestrant 2 Fulvestrant 2 trastuzumab deruxtecan 1 ribociclib 1 palbociclib 1 exemestane 1 abemaciclib 1 Selective Estrogen Receptor Modulators 1 RAD1901 1 Letrozole 1 Gonadotropin-Releasing Hormone 1 Everolimus 1 Anastrozole 1 Alpelisib 1 AZD9833 1 AZD5305 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06382948 2026-04-03

ADELA

MedSIR

Phase 3 Recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡